• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID Back to Search Results
Model Number 26606
Device Problem Failure to Advance (2524)
Patient Problems Hemorrhage/Bleeding (1888); Perforation of Vessels (2135)
Event Date 12/02/2020
Event Type  Injury  
Event Description
It was reported that vessel perforation occurred.The 99% stenosed target lesion was located in the severely tortuous and non-calcified internal carotid artery.A bsc filterwire was placed in position and the lesion was pre-dilated with a sterling balloon.A 8.0-29 carotid wallstent was the advanced to the lesion.The device had difficulties in crossing but eventually crossed and the stent was placed without further problems.Subsequently, the lumen was viewed with an opticross 18 imaging catheter and post-dilatation using a 6mm sterling balloon.Bleeding was observed from the center of the stent.Protamine was injected, dilatation using a 6mm balloon was performed, and the neck region was compressed to stop the bleeding and the procedure was completed.The patient left the operating room without symptoms.Physician commented that the bleeding might have been caused by the stent getting caught while passing through the stenosis.No further patient complications were reported.
 
Event Description
It was reported that vessel perforation occurred.The 99% stenosed target lesion was located in the severely tortuous and non-calcified internal carotid artery.A bsc filterwire was placed in position and the lesion was pre-dilated with a sterling balloon.A 8.0-29 carotid wallstent was the advanced to the lesion.The device had difficulties in crossing but eventually crossed and the stent was placed without further problems.Subsequently, the lumen was viewed with an opticross 18 imaging catheter and post-dilatation using a 6mm sterling balloon.Bleeding was observed from the center of the stent.Protamine was injected, dilatation using a 6mm balloon was performed, and the neck region was compressed to stop the bleeding and the procedure was completed.The patient left the operating room without symptoms.Physician commented that the bleeding might have been caused by the stent getting caught while passing through the stenosis.No further patient complications were reported.It was further reported that vessel perforation was not reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAROTID WALLSTENT
Type of Device
STENT, CAROTID
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11004477
MDR Text Key221484419
Report Number2134265-2020-17551
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/28/2023
Device Model Number26606
Device Catalogue Number26606
Device Lot Number0024839009
Was Device Available for Evaluation? No
Date Manufacturer Received12/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BALLOON CATHETER USED: STERLING 3.5/X30; BALLOON CATHETER USED: STERLING 3.5/X30; GUIDEWIRE USED: FILTERWIRE; GUIDEWIRE USED: FILTERWIRE; BALLOON CATHETER USED: STERLING 3.5/X30; GUIDEWIRE USED: FILTERWIRE
Patient Outcome(s) Required Intervention;
-
-